ELSCINT BIOMEDICAL INVESTMENT
ELSCINT BIOMEDICAL INVESTMENT
Status:
Active
Similar Organizations
Acina Investments
Acina Investments was added in 2012.
Scenic Investments
Scenic Investments was added in 2013.
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2006-09-27 | Gamida Cell | Elscint Biomedical Investment investment in Series D - Gamida Cell | 16 M USD |
More informations about "Elscint Biomedical Investment"
Elscint Biomedical Investment - Investments, Portfolio & Company โฆ
Sep 27, 2006 Elscint Biomedical Investment was added in 2010. Gamida Cell Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood โฆSee details»
Elscint - Wikipedia
Elscint (perhaps a portmanteau of the words "electronic" and "scientific, but more likely of "El" as in "El Al", and "Scint", as in scintillation, referring to the type of radiation detector used in Nuclear Medicine as in Elscint's first products.) was founded in 1969 by Dr. Avraham Suhami, who was a nuclear physics professor at the Technion โ Israel Institute of Technology at the time, after receiving encouragement to apply his scientific and technical knowledge for commercial applicaโฆSee details»
Elscint Biomedical Investment - Crunchbase
Elscint Biomedical Investment was added in 2010.See details»
Elscint Biomedical Investment - Israeli VC and Private Equity
Work Email* (please provide your email in the organization) Position* Notes. Send Create Free Account. Create Free Account. 8 Characters, Uppercase letter (A-Z), Lowercase letter (a-z), โฆSee details»
Gamida Cell garners $16M in VC | Fierce Biotech
Sep 26, 2006 Israel's Gamida Cell $16 million dollars in a fourth round led by Israel Healthcare Ventures. Elscint Biomedical Investment, Denali Ventures, Biomedical Investments and TEVA โฆSee details»
Elscint returns with biomedical investment fund:
Feb 26, 2001 Elscint, an Israeli company formerly known for its imaging businesses which it disposed of in 1998 for a total of $603 million, is moving back into early-stage biomedical โฆSee details»
Elscint BioMedical - CB Insights
Elscint BioMedical operates as a venture capital company. Use the CB Insights Platform to explore Elscint BioMedical's full profile.See details»
Elbit sells off Elscint businesses through deals with Picker and GE
Sep 16, 1998 Tamir stated that Elscint must improve the return on investment it has turned in over the last several years. The company has been able to grow its revenues, but profits โฆSee details»
Elscint returns with biomedical investment fund: :: Pink Sheet
Feb 26, 2001 Elscint, an Israeli company formerly known for its imaging businesses which it disposed of in 1998 for a total of $603 million, is moving back into early-stage biomedical โฆSee details»
Elscint sets up biotech investment unit - Pharmaceutical industry โฆ
Feb 12, 2001 Israel's Elscint, which is listed on the New York Stock Exchange, hasestablished a wholly-owned subsidiary, Elscint BioMedical, to focus on investments in early-stage โฆSee details»
Biomedical Investments โ 5 Portfolio companies, 7 Investments, โฆ
Biomedical Investments appeared to be the VC, which was created in 1997. ... Biomedical Investments works on 38 percentage points more the average amount of lead investments โฆSee details»
Elscint divestiture may be harbinger of more medical imaging โฆ
Sep 30, 1998 Elscint s mammography products, which include Glory and MAM-CH22S, produced minuscule revenues in 1997, but the company in the spring granted European โฆSee details»
Investing in Stem Cell Research the Safer Way | Seeking Alpha
Sep 29, 2006 The investors were Israel Healthcare Ventures Ltd. and existing investors Denali Ventures, Biomedical Investments, Elscint Biomedical Investment (a subsidiary of Elbit โฆSee details»
Accelerating Medical Solutions in Israel: Building a Global Life ...
Innovation around the CT scanner (Elscint, later sold to GE Medical) and imaging systems (such as Given Imaging). Lagging Behind Despite these remarkable achievements, the life science โฆSee details»
Gamida Cell raises $16m in fourth financing round - Globes
Sep 27, 2006 The company says the capital will be used to support its cell tissue regeneration product pipeline. Israeli start-up Gamida-Cell Ltd. announced today that it had raised $16 โฆSee details»
Lifecore Biomedical: An Interesting CDMO Pure Play
Lifecore (NASDAQ:LFCR) is a fully integrated CDMO (contract development and manufacturing organization) specializing in developing, filling, and finishing sterile injectable pharmaceutical ...See details»
Biomedical Investments - Crunchbase Investor Profile & Investments
Biomedical Investments (BMI) is an Israeli-based private investment firm, which specializes in the healthcare field (medical devices and biotechnology). The company focuses its investments on โฆSee details»
Lifecore Biomedical to Present at Stephens Annual Investment โฆ
Lifecore Biomedical, Inc. Contact Information: Vida Strategic Partners Stephanie Diaz (Investors) 415-675-7401 [email protected] Tim Brons (Media) 415-675-7402 [email protected] โฆSee details»
Major investments in domestic firms to rebuild Canadaโs ...
Mar 16, 2021 As a CDMOโa contract development and manufacturing organizationโour investment will provide valuable services to support Canadian and foreign biopharmaceutical โฆSee details»